NYSE:LLYPharmaceuticals
Eli Lilly Faces Actos RICO Class Action Test To Growth Story
A national class of third party payors has been certified in a RICO lawsuit tied to alleged concealment of bladder cancer risk associated with diabetes drug Actos.
The case targets Eli Lilly (NYSE:LLY) alongside Takeda and could expose the company to material legal, financial and reputational risk across a wide group of U.S. insurers and payors.
Class certification expands potential claimant participation and may influence how future liabilities and settlement discussions develop.
Eli...